GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » Total Assets

Eone Diagnomics Genome Center Co (XKRX:245620) Total Assets : ₩164,095 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co Total Assets?

Eone Diagnomics Genome Center Co's Total Assets for the quarter that ended in Mar. 2024 was ₩164,095 Mil.

During the past 12 months, Eone Diagnomics Genome Center Co's average Total Assets Growth Rate was -17.20% per year. During the past 3 years, the average Total Assets Growth Rate was 18.30% per year. During the past 5 years, the average Total Assets Growth Rate was 27.80% per year.

During the past 9 years, Eone Diagnomics Genome Center Co's highest 3-Year average Total Assets Growth Rate was 190.40%. The lowest was 18.30%. And the median was 101.40%.

Total Assets is connected with ROA %. Eone Diagnomics Genome Center Co's annualized ROA % for the quarter that ended in Mar. 2024 was -15.80%. Total Assets is also linked to Revenue through Asset Turnover. Eone Diagnomics Genome Center Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.06.


Eone Diagnomics Genome Center Co Total Assets Historical Data

The historical data trend for Eone Diagnomics Genome Center Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eone Diagnomics Genome Center Co Total Assets Chart

Eone Diagnomics Genome Center Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only 96,400.09 160,304.93 186,938.23 192,010.59 173,518.95

Eone Diagnomics Genome Center Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 206,058.66 201,845.61 192,097.79 173,518.95 164,094.50

Eone Diagnomics Genome Center Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Eone Diagnomics Genome Center Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=39111.452+134407.497
=173,519

Eone Diagnomics Genome Center Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=41868.018+122226.483
=164,095

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eone Diagnomics Genome Center Co  (XKRX:245620) Total Assets Explanation

Total Assets is connected with ROA %.

Eone Diagnomics Genome Center Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-26670.592/( (173518.949+164094.5)/ 2 )
=-26670.592/168806.7245
=-15.80 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Eone Diagnomics Genome Center Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=9707.656/( (173518.949+164094.5)/ 2 )
=9707.656/168806.7245
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Eone Diagnomics Genome Center Co Total Assets Related Terms

Thank you for viewing the detailed overview of Eone Diagnomics Genome Center Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014
Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines